Archiwum kwartalnika medycznego "Okulistyka"
Wydanie specjalne czerwiec 2018
Polski tytuł
English title
- Ranibizumab in Drug Prescription Program – Analysis of the Treatment Results of the Neovascular Age-related Macular Degeneration in PRN Scheme Authors: Andrzej Stankiewicz, Dagmara Dziurkowska.
- Therapy Individualization – Does it Influence the Efficacy of Ranibizumab Treatment in Neovascular Age-related Macular Degeneration? Autor: Katarzyna Mozolewska-Piotrowska
- Results of Switch from Intravitreal Aflibercept to Ranibizumab in Patients with Exudative Age-related Macular Degeneration – Own Experience Authors: Anna Michalska, Martyna Piotrowska, Paweł Stala
- Ranibizumab Therapy as an Alternative in Patients Participating in Drug Prescription Program in Neovascular Age-related Macular Degeneration not Responding to Primary Therapy with Aflibercept Authors: Dorota Kaczmarek, Marta Dembowska, Maria Pomorska, Radosław Kaczmarek
- Retinal Angiomatous Proliferation – Diagnosis and Treatment in the Context of the Neovascular Age-related Macular Degeneration Drug Prescription Programme. Own Experience Authors: Barbara Kozub, Barbara Terelak-Borys, Joanna Mokrzecka, Magdalena Górska, Urszula Stachowska, Iwona Grabska-Liberek
- Cardiovascular Risk Factors and the Response to Anti-Vascular Endothelial Growth Factor Therapy of Exudative Age-related Macular Degeneration Authors: Joanna Łądkowska, Barbara Krupa-Szafran, Maciej Gawęcki, Marek Szołkiewicz
- Optical Coherence Tomography-angiography as a Modern Method of Diagnostic and Monitoring Treatment Effects in Age-related Macular Degeneration in Patients Treated with anti-VEGF Intravitreal Injections As a Part of the National Health Fund Drug Prescription Authors: Anna Heinke, Katarzyna Michalska-Małecka
- Organization of Work with Patients Treated for Wet Age-related Macular Degeneration within Drug Administration Program – Additional Tools Facilitating Therapy Efficiency Monitoring Authors: Karol Nienartowicz, Marzena Jankowska